Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Angela Dascalescu"'
Autor:
Vlad Andrei Cianga, Cristina Rusu, Mariana Pavel-Tanasa, Angela Dascalescu, Catalin Danaila, Sebastian Harnau, Carmen-Mariana Aanei, Petru Cianga
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionNatural killer (NK) cells are key anti-tumor effectors of the innate immunity. Phenotypic differences allow us to discriminate in between three functional stages of maturation, named immature, mature and hypermature that are distinctive i
Externí odkaz:
https://doaj.org/article/fda948deb3b44ddf9e83d704cf612f63
Autor:
Dalma Deak, Cristina Pop, Alina-Andreea Zimta, Ancuta Jurj, Alexandra Ghiaur, Sergiu Pasca, Patric Teodorescu, Angela Dascalescu, Ion Antohe, Bogdan Ionescu, Catalin Constantinescu, Anca Onaciu, Raluca Munteanu, Ioana Berindan-Neagoe, Bobe Petrushev, Cristina Turcas, Sabina Iluta, Cristina Selicean, Mihnea Zdrenghea, Alina Tanase, Catalin Danaila, Anca Colita, Andrei Colita, Delia Dima, Daniel Coriu, Hermann Einsele, Ciprian Tomuleasa
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Therapy for acute lymphoblastic leukemia (ALL) are currently initially efficient, but even if a high percentage of patients have an initial complete remission (CR), most of them relapse. Recent data shows that immunotherapy with either bi
Externí odkaz:
https://doaj.org/article/cae0432cf043402aa1b9fa3ef8bd41ec
Autor:
Mihaela Mențel, Raluca Oană, Iuliu Ivanov, Ion Antohe, Vlad Andrei Cianga, Loredana Dragoș, Angela Dascalescu, Catalin Danaila
Publikováno v:
Archive of Clinical Cases
Blastic plasmacytoid dendritic cell neoplasms (BPDCNs) are extremely rare and aggressive hematological malignancies that derive from precursors of plasmacytoid dendritic cells (pDC) and frequently involve skin lesions and bone marrow infiltration. Th
Autor:
Ciprian Tomuleasa, Bobe Petrushev, Ciprian Jitaru, Angela Dascalescu, Monica Padurariu-Covit, Delia Dima, Ion Antohe, Andrei Colita, Alina Tanase, Sabina Iluta, Alexandra Andries, Anca Vasilache, Anca Colita, Mihnea Zdrenghea, Dalma Deak-Mihaly, Sergiu P. Paşca, Andrei Roman, Anca Bojan
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 4483, p 4483 (2021)
Volume 10
Issue 19
Journal of Clinical Medicine, Vol 10, Iss 4483, p 4483 (2021)
Volume 10
Issue 19
Introduction. Primary central nervous system lymphoma is an uncommon form of extranodal non-Hodgkin’s lymphoma, with increasing incidence, a relatively aggressive course and a poor 5-year survival. Because of its localization, the therapeutic compo
Autor:
Adriana Sireteanu, Amalia Titieanu, Iuliu Ivanov, Angela Dascalescu, Petru Cianga, Catalin Danaila, Mihaela Zlei, Ion Antohe, Mariana Pavel Tanasa
Publikováno v:
Immunobiology. 226(1)
Acute Myeloid Leukaemia (AML) is a neoplasia characterised by rapid proliferation and an increased rate of relapses. The AML blasts display features of antigen-presenting cells (APC), and thus can directly modulate the anti-tumour T cell responses. T
Autor:
Mihaela Zlei, Adriana Sireteanu, Iuliu Ivanov, Raluca Oană, Oana Boca, Petru Cianga, Ion Antohe, Angela Dascalescu, Catalin Danaila
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 26, Iss 1, Pp 87-94 (2018)
Background: Acute basophilic leukemia is a rare subtype of acute myeloid leukemia, as categorized by the 2008 World Health Organization classification of myeloid neoplasms. Acute basophilic leukemia diagnosis requires thorough morphological, cytochem
Autor:
Walther Bild, Ion Antohe, Dan Ferariu, Alexandru Gluvacov, Mugurel Bosanceanu, Angelica Slatineanu, Angela Dascalescu, Catalin Danaila, Amalia Merticariu, Georgiana Butura
Publikováno v:
Archive of Clinical Cases. :24-30
Primary and secondary cardiac involvements in lymphomas are extremely rare and sometimes ill-defined entities. Thorough clinical and imagistic investigation is crucial to evaluate disease extension and its impact on cardiac function. Chemotherapeutic
Autor:
Franco Cavalli, Zvenyslava Masliak, Olga Samoilova, André Bosly, Tadeusz Robak, Huiqiang Huang, Angela Dascalescu, Jan Maciej Zaucha, Kateryna Vilchevskaya, Brendan Rooney, Andrew Belch, Charles M. Farber, Udomsak Bunworasate, Lixia Pei, Jan Novák, Johannes Drach, Helgi van de Velde
Publikováno v:
Leukemialymphoma. 59(4)
This post-hoc subanalysis of the LYM-3002 phase 3 study assessed the efficacy and safety of substituting vincristine in rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHOP; n = 42) for bortezomib (VR-CAP; n = 38) in a subgroup of 80 mantl
Autor:
Alina Tanase, Nicolae Leopold, Minodora Desmirean, Dalma Deak, Wilhelm-Thomas Micu, Ioana Berindan-Neagoe, Alexandra Sacu, Horia Bumbea, Laura Pop, Romulus Tetean, Ancuta Jurj, Andrei Colita, Cristian Berce, Ciprian Tomuleasa, Bobe Petrushev, Adrian P. Trifa, Vlad Moisoiu, Mihnea Zdrenghea, Alin Moldovan, Angela Dascalescu, Sergiu Pasca, Rares Stiufiuc, Delia Dima, Ioana Frinc, Bogdan Fetica, Grigore Gafencu, Sonia Selicean, Emil Burzo
Even if considered a cumulative and not a proliferative CD5+ B-cell neoplasm, chronic lymphocytic leukemia (CLL) has a proliferation rate higher than that recognized earlier, especially in the lymphoid tissues. Some patients with CLL develop a clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37162a29abcc8f3d4265cc42f2f326f5
Autor:
Angela Dascalescu, Catalin Danaila, Karina Bilavski, Amalia Merticariu, Ion Antohe, Mihaela Zlei, Petru Cianga, Georgiana Butura
Publikováno v:
Archive of Clinical Cases. :138-144
Current management of acute myeloblastic leukemia (AML) involves induction chemotherapy followed by risk stratified consolidation approaches, consisting of high dose chemotherapy or allogeneic stem cell transplantation. AML patients are at high risk